Page last updated: 2024-09-04

moxifloxacin and Dyspnea

moxifloxacin has been researched along with Dyspnea in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (80.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Chen, F; Chen, Y; Fang, Q; Hu, S; Jiang, J; Liang, T; Lu, S; Sheng, J; Wei, N; Wu, L; Zheng, S; Zhou, J1
Fukao, A; Horikawa, S; Ikeue, T; Noguchi, S; Ohi, I; Sugita, T; Tanaka, E; Terashita, S; Yoshida, H1
Diethelm, M; Schuster, S1
Dannecker, G; Hess, S; Hospach, T; Magdorf, K; Nossal, R; Uhlemann, F1
Arvis, P; Choudhri, SH; Haverstock, D; Kruesmann, F; Miravitlles, M; Perroncel, R1

Reviews

1 review(s) available for moxifloxacin and Dyspnea

ArticleYear
Sputum colour and bacteria in chronic bronchitis exacerbations: a pooled analysis.
    The European respiratory journal, 2012, Volume: 39, Issue:6

    Topics: Anti-Bacterial Agents; Aza Compounds; Bacteria; Bronchitis, Chronic; Color; Disease Progression; Dyspnea; Female; Fluoroquinolones; Gentian Violet; Humans; Male; Moxifloxacin; Multicenter Studies as Topic; Phenazines; Pneumonia, Bacterial; Quinolines; Randomized Controlled Trials as Topic; Sex Factors; Sputum

2012

Other Studies

4 other study(ies) available for moxifloxacin and Dyspnea

ArticleYear
First report of manic-like symptoms in a COVID-19 patient with no previous history of a psychiatric disorder.
    Journal of affective disorders, 2020, 12-01, Volume: 277

    Topics: Antibodies, Viral; Antipsychotic Agents; Antiviral Agents; Betacoronavirus; Bipolar Disorder; Brain; Chest Pain; China; Clinical Laboratory Techniques; Cobicistat; Coronavirus Infections; COVID-19; COVID-19 Testing; Darunavir; Dyspnea; Fever; Glucocorticoids; Humans; Indoles; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Moxifloxacin; Olanzapine; Pandemics; Pharyngitis; Pneumonia, Viral; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2

2020
Pleuritis Caused by Mycobacterium kyorinense without Pulmonary Involvement.
    Internal medicine (Tokyo, Japan), 2017, Oct-15, Volume: 56, Issue:20

    Topics: Clarithromycin; Cough; Dyspnea; Exudates and Transudates; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Mycobacterium Infections; Pleurisy; Tomography, X-Ray Computed

2017
[Achilles heel of COPD].
    Praxis, 2013, Jul-03, Volume: 102, Issue:14

    Topics: Achilles Tendon; Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents; Aza Compounds; Diagnosis, Differential; Disease Progression; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dyspnea; Fluoroquinolones; Humans; Male; Mobility Limitation; Moxifloxacin; Ofloxacin; Prednisone; Pulmonary Disease, Chronic Obstructive; Quinolines; Respiratory Insufficiency; Rupture, Spontaneous; Ultrasonography

2013
Life-threatening disseminated tuberculosis as a complication of TNF-α blockade in an adolescent.
    European journal of pediatrics, 2011, Volume: 170, Issue:10

    Topics: Acquired Hyperostosis Syndrome; Adalimumab; Adolescent; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Antitubercular Agents; Aza Compounds; Drug Therapy, Combination; Dyspnea; Ethambutol; Female; Fluoroquinolones; Humans; Immunocompromised Host; Immunosuppressive Agents; Moxifloxacin; Quinolines; Severity of Illness Index; Shock, Septic; Treatment Outcome; Tuberculosis, Miliary; Tumor Necrosis Factor-alpha

2011